| Literature DB >> 25629697 |
Sergio Sánchez1, María Teresa Llorente1, María Aurora Echeita1, Silvia Herrera-León1.
Abstract
Escherichia coli serogroups O5, O15, O26, O45, O55, O76, O91, O103, O104, O111, O113, O118, O121, O123, O128, O145, O146, O157, O165, O172, and O177 are the O-antigen forms of the most clinically relevant Shiga toxin-producing E. coli (STEC) serotypes. In this study, three multiplex PCR assays able to specifically detect these 21 serogroups were developed and validated. For this purpose, the O-antigen gene clusters of E. coli O5 and O76 were fully sequenced, their associated genes were identified on the basis of homology, and serogroup-specific primers were designed. After preliminary evaluation, these two primer pairs were proven to be highly specific and suitable for the development of PCR assays for O5 and O76 serogroup identification. Specific primers were also designed for serogroups O15, O45, O55, O91, O104, O113, O118, O123, O128, O146, O157, O165, O172, and O177 based on previously published sequences, and previously published specific primers for serogroups O26, O103, O111, O121, and O145 were also included. These 21 primer pairs were shown to be specific for their target serogroup when tested against E. coli type strains representing 169 known O-antigen forms of E. coli and Shigella and therefore suitable for being used in PCR assays for serogroup identification. In order to validate the three multiplex PCR assays, 22 E. coli strains belonging to the 21 covered serogroups and 18 E. coli strains belonging to other serogroups were screened in a double-blind test and their sensitivity was determined as 1 ng chromosomal DNA. The PCR assays developed in this study could be a faster, simpler, and less expensive strategy for serotyping of the most clinically relevant STEC strains in both clinical microbiology and public health laboratories, and so their development could benefit for clinical diagnosis, epidemiological investigations, surveillance, and control of STEC infections.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25629697 PMCID: PMC4309606 DOI: 10.1371/journal.pone.0117660
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers and concentrations used in the serogroup-specific multiplex PCR assays.
| Multiplex | O type | Gene | Primer | nM | Oligonucleotide sequence (5′-3′) | PCR product (bp) | Reference |
|---|---|---|---|---|---|---|---|
| 1 | O5 | Wzx | wzx5_F | 800 | CTTATCCGATTAATGGCTTC | 132 | This study |
| wzx5_R | 800 | TAGTCGATTTGCTTTTATGG | This study | ||||
| 1 | O91 | Wzy | wzy91_F9 | 600 | TTTTCTGGAATGCTTGATGA | 188 | This study |
| wzy91_R5 | 600 | ATAATTTTACGCCGTGTTTG | This study | ||||
| 1 | O26 | Wzx | 5′O26 | 400 | ACTCTTGCTTCGCCTGTT | 268 | [ |
| 3′O26 | 400 | CAGCGATACTTTGAACCTTAT | [ | ||||
| 1 | O103 | wzx | 5′O103_F | 400 | TATCCTTCATAGCCTGTTGTT | 327 | [ |
| wzx103_R1 | 400 | TTATAATAGTAATAAGCCAGACACC | This study | ||||
| 1 | O145 | wzx | 5′O145.6 | 400 | TTGAGCACTTATCACAAGAGATT | 418 | [ |
| 3′O145.B | 400 | GATTGAATAGCTGAAGTCATACTAAC | [ | ||||
| 1 | O121 | wzx | 5′O121 | 200 | GTAGCGAAAGGTTAGACTGG | 651 | [ |
| 3′O121 | 200 | ATGGGAAAGCTGATACTGC | [ | ||||
| 1 | O111 | wzx | 5′O111.3 | 400 | GTTGCGAGGAATAATTCTTCA | 829 | [ |
| 3′O111.2 | 400 | CCATAGATATTGCATAAAGGC | [ | ||||
| 2 | O55 | wzx | wzx55_F | 200 | ATCGCAATTGCAATAAACTC | 144 | This study |
| wzx55_R1 | 200 | CCCAACTCTAGTAGATAAAAGCC | This study | ||||
| 2 | O128 | wzx | wzx128_F2 | 200 | TTTCGATCGTCTTGTTCAGG | 193 | This study |
| wzx128_R1 | 200 | CAATGGGCAATTAACACAGAG | This study | ||||
| 2 | O113 | wzy | wzy113_F1 | 400 | TAACGGGATTAGAAGTGGAT | 294 | This study |
| wzy113_R1 | 400 | ATATAAGGCAGAAATGAGAGG | This study | ||||
| 2 | O146 | wzy | wzy146_F2 | 800 | ATCAGTTCATGGGTTGTATTC | 390 | This study |
| wzy146_R1 | 800 | AGGAACATGGATGAAAGAAG | This study | ||||
| 2 | O76 | wzx | wzx76_F4 | 400 | CATATGCAGATTGAAGGTAG | 550 | This study |
| wzx76_R5 | 400 | GAAAGCCATAAAGTGCC | This study | ||||
| 2 | O45 | wzx | wzx45_F | 200 | GACTTTCGTTGCGTTGTG | 608 | This study |
| wzx45_R1 | 200 | CTGCAAGTGTAGCGAAAAC | This study | ||||
| 2 | O177 | wzx | wzx177_F2 | 400 | TCGGTGTTTGAAGGGGAAG | 767 | This study |
| wzx177_R2 | 400 | GTCCATGCATATGCCGTTC | This study | ||||
| 3 | O157 | wzx | wzx157_F3 | 600 | CTCAATTTATAAAAAAGACGCTC | 111 | This study |
| wzx157_R1 | 600 | TCCAAATATTAACGACTTCACTAC | This study | ||||
| 3 | O15 | wzx | wzx15_F1 | 200 | GCGTTGCCTACTTACTTATTATC | 225 | This study |
| wzx15_R2 | 200 | ATGCAAGTCCAGCCAAAC | This study | ||||
| 3 | O104 | wzx | wzx104_F | 400 | CGGTGTATTAAGAAGTGTTGTC | 272 | This study |
| wzx104_F | 400 | ATACTCCCCATAGAAACGC | This study | ||||
| 3 | O118 | wzx | wzx118_F | 200 | TGGAGAACAGATAGCAAGAGG | 409 | This study |
| wzx118_R | 200 | TATCCGACAAACACGAACC | This study | ||||
| 3 | O123 | wzx | wzx123_F | 200 | GAAAGAACAGAATCAGACTATGC | 510 | This study |
| wzx123_R | 200 | TGTGCTAGCGCTAAAGGAC | This study | ||||
| 3 | O165 | wzx | wzx165_F | 200 | AACTGTTTATCCGAAGTGGTAG | 651 | This study |
| wzx165_R | 200 | CACGCTTTAACGCATACAG | This study | ||||
| 3 | O172 | wzx | wzx172_F | 200 | ATTGGGTAGCCTCAGTAAAG | 823 | This study |
| wzx172_R | 200 | CAGTCCAAACAGTGACAGTATC | This study |
aGenBank accession numbers for each of the gene targets: O5wzx (KM881565); O91wzy (AY035396); O103wzx (AP010958); O55wzx (NC_013941); O128wzx (AY217096); O113wzx (AF172324); O146wzx (DQ465249); O76wzx (KM881564); O45wzx (AY771223); O177wzx (DQ008593); O157wzx (AE005174); O15wzx (AY647261); O104wzx (AF361371); O118wzx (DQ990684); O123wzx (DQ676933); O165wzx (GU068045); O172wzx (AY545992).
bCross reaction with wzx from E. coli O9.
cCross reaction with wzx from E. coli O151.
Fig 1E. coli O5 and O76 O-antigen gene clusters.
All genes are transcribed in a direction from the JUMPstart sequence to gnd.
Putative genes in the E. coli O5 O-antigen gene cluster.
| Gene | Location in sequence | G+C content (%) | Similar protein(s), species (GenBank accession no.) |
| Putative function of protein |
|---|---|---|---|---|---|
| rmlB | 260–1153 | 42.4 | RmlB, | 100 | dTDP-glucose 4,6-dehydratase |
| rmlA | 1153–2016 | 38.4 | RmlA, | 100 | Glucose-1-phosphate thymidylyltransferase |
| fdtA | 2020–2415 | 36.1 | FdtA, | 100 | dTDP-6-deoxy-3,4-keto-hexulose isomerase |
| fdtA | 2412–2879 | 35.3 | FdtA, | 100 | dTDP-6-deoxy-3,4-keto-hexulose isomerase |
| fdtB | 2876–3760 | 36.3 | FdtB, | 99 | Aminotransferase |
| wzx | 3985–5241 | 31.9 | Wzx, | 100 | O-antigen flippase |
| wzy | 5242–6558 | 31.7 | Wzy, | 100 | O-antigen polymerase |
| wbuM | 6542–7420 | 31.4 | WbuM, | 100 | Glycosyltransferase |
| ORF9 | 7420–8088 | 30.8 | Putative protein, | 100 | Haloacid dehalogenase-like hydrolase |
| wbuO | 8628–8879 | 30.2 | WbuO, | 100 | Serine transferase |
| amsE | 8872–9699 | 33.9 | AmsE, | 100 | Amylovoran biosynthesis protein |
aaa, amino acid.
Putative genes in the E. coli O76 O-antigen gene cluster.
| Gene | Location in sequence | G+C content (%) | Similar protein(s), species (GenBank accession no.) |
| Putative function of protein |
|---|---|---|---|---|---|
| ORF1 | 176–940 | 29.4 | Putative protein, | 100 | Glycosyltransferase |
| wzx | 927–2165 | 30.1 | Wzx, | 100 | O-antigen flippase |
| ORF2 | 2162–2731 | 35.3 | Putative protein LbH_MAT_like, | 100 | Acetyltransferase |
| wzy | 2731–3237 | 25.3 | Wzy, | 100 | O-antigen polymerase |
| wzy | 3258–3962 | 30.6 | Wzy, | 100 | O-antigen polymerase |
| wcaN | 3922–4821 | 31.8 | WcaN, | 100 | Glycosyltransferase |
| rfaG | 4847–5872 | 32.8 | RfaG, | 100 | Glycosyltransferase |
| galE | 5927–6739 | 34.9 | GalE, | 100 | UDP-glucose 4-epimerase |
| galE | 6684–6950 | 33.4 | GalE, | 100 | UDP-glucose 4-epimerase |
a aa, amino acid.
Fig 2Agarose gel electrophoresis of the PCR products obtained from E. coli type strains belonging to the 21 covered serogroups by using the three multiplex PCR assays.
(a) Multiplex 1: lanes 1 and 9, 100 bp DNA ladder; lane 2, O5; lane 3, O91; lane 4, O26; lane 5, O103; lane 6, O145; lane 7, O121; lane 8, O111. (b) Multiplex 2: lanes 1 and 9, 100 bp DNA ladder; lane 2, O55; lane 3, O128; lane 4, O113; lane 5, O146; lane 6, O76; lane 7, O45; lane 8, O177. (c) Multiplex 3: lanes 1 and 9, 100 bp DNA ladder; lane 2, O157; lane 3, O15; lane 4, O104; lane 5, O118; lane 6, O123; lane 7, O165; lane 8, O172.